scPharmaceuticals Inc. provided revenue guidance for the full year 2023. For the period, the company anticipates net revenue to be in a range of $13.4 million to $13.6 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 USD | 0.00% | +0.86% | -25.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.04% | 169M | |
+34.26% | 698B | |
+26.51% | 568B | |
-4.58% | 358B | |
+18.80% | 328B | |
+3.81% | 283B | |
+16.11% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.89% | 165B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023